US Patent 7790152 Enhancer for antibody to lymphocytic tumors
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+290 characters)
Article
Patent abstract
An enhancer, for treatment of lymphocytic tumors, of an antibody that specifically binds to protein having the amino acid sequence as set forth in SEQ ID NO: 1 and that has a cytotoxic activity, said enhancer comprising a biological response modifier as an active ingredient.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07790152 Enhancer for antibody to lymphocytic tumors US Patent 7790152 Enhancer for antibody to lymphocytic tumors
Infobox
Patent Number
0779015200
Patent Number
779015200
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
077901520
Date of Patent
September 7, 2010
0Patent Application Number
104280850
Date Filed
May 2, 2003
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
077901520
Date of Patent
September 7, 2010
0Patent Application Number
104280850
Date Filed
May 2, 2003
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07790152 Enhancer for antibody to lymphocytic tumors
Infobox
Is a
Patent jurisdiction
Patent number
07790152
Date of patent
September 7, 2010
Patent application number
10428085
Date Filed
May 2, 2003
Patent primary examiner
Find more entities like US Patent 7790152 Enhancer for antibody to lymphocytic tumors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
